150 patients very late stage RCT showing no significant difference. Treatment very late, average 16.6 days after symptom onset.
Data favorable to HC
Q was deleted in the second version, see analysis .
Q] accelerate[s] the alleviation of clinical symptoms"
"More rapid alleviation of clinical symptoms with SOC plus HC
Q than with SOC alone was observed during the second week since randomization".
"The efficacy of HC
Q on the alleviation of symptoms, HR 8.83 [1.09-71.3], was more evident when the confounding effects of other anti-viral agents were removed"
no virological cure, ↓21.5%, p=0.51, risk of no virological cure at day 21